Achieve Life Science Inc. (ACHV)

[cjstocksup]

ACHV has no dilution, cash on hand and only did the RS to be Nasdaq compliant with their big drug coming to market that is bigger than Chantix. If anyone is having troubles adding, buying etc. or trading call your brokers so they will speed up trading before the open of the markets. Based on yesterday we should open between $12.00 and $18.00 to start trading. cytisinicline is a multi billion dollar drug!

Over the past decade or so, we’ve seen a big push to get smokers to quit smoking cigarettes. However, doing so is very difficult. In order to fight the addiction, smokers spend more than $21 billion annually on products that are designed to help them quit.

With that ACHV is working on a smoking cessation product known as cytisinicline, and has had some pretty strong success. In fact, about a month ago, the company released the results from an investigator-initiated study that compared cytisinicline to the top smoking cessation drug on the market, Chantix.

Importantly, cytisinicline outperformed Chantix, setting the stage for the company to push toward commercialization with a drug that represents a multi-billion dollar opportunity.

So, even without the short squeeze, the promise offered through cytisinicline suggests that you should be paying close attention to ACHV stock.